Linnaeus Therapeutics, Inc. is a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics that target G protein-coupled receptors. The company was formed and launched in partnership with the UPstart incubator at the University of Pennsylvania’s Penn Center for Innovation (PCI).
Company Details
- Employees
- 5
- Founded
- -
- Address
- 30 Washington Ave,
- Phone
- 856-433-1300
- in****@****stx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- linnaeustx.com
- Keywords
- Cancer Therapy.
- HQ
- Haddonfield, New Jersey
Linnaeus Therapeutics, Inc. Questions
Linnaeus Therapeutics, Inc.'s helpline number is 856-433-1300
Linnaeus Therapeutics, Inc.'s website is linnaeustx.com
Linnaeus Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/linnaeustx
Linnaeus Therapeutics, Inc. has
5 employees.
View email and phone details for 5
employees at Linnaeus Therapeutics, Inc..
Linnaeus Therapeutics, Inc.'s industry is
Biotechnology Research
Linnaeus Therapeutics, Inc.'s top competitors are
Interius Biotherapeutics,
Carnegie Pharmaceuticals Llc,
Macrophage Therapeutics, Inc.,
Lexeo Therapeutics,
Novarock Biotherapeutics Ltd,
Armas Pharmaceuticals,
Ingenio Diagnostics,
Salix Pharmaceuticals,
Amneal Pharmaceuticals,
Seed Therapeutics.
Linnaeus Therapeutics, Inc.'s support email address is info@linnaeustx.com
Linnaeus Therapeutics, Inc.'s categories are Biotechnology Research
Linnaeus Therapeutics, Inc.'s founding year is 2016
